Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
As a multisystem disease, metabolic dysfunction-associated fatty liver disease (MAFLD) is closely linked to the onset and progression of coronary heart disease (CHD). Ultrasonographic fatty liver indicator (US-FLI) is a semi-quantitative tool for evaluating the degree of hepatic steatosis. Our study aims to explore the relationship between US-FLI based on MAFLD and the severity of CHD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:
• Patients older than 18 years old
• Patients underwent ICA due to chest pain, chest tightness or other reasons in our hospital from August 2022 to December 2023 were included in our study
Locations
Other Locations
China
The Second Affiliated Hospital of Chongqing Medical University
RECRUITING
Chongqing
Contact Information
Primary
Tingqiu Wang
w857683014@163.com
+8617815370539
Time Frame
Start Date: 2022-07-01
Estimated Completion Date: 2025-04-28
Participants
Target number of participants: 190
Treatments
Non-CAD group
non-coronary artery disease group
CAD group
coronary artery disease group
SS≤22 group
SYNTAX score ≤22
SS≥23 group
SYNTAX score ≥23
Related Therapeutic Areas
Sponsors
Leads: Chongqing Medical University